Elixinol cuts H1 loss and announces deal to sell US hemp business by Adam Sheldon September 2, 2026September 3, 2026 Hemp Foods Australia parent Elixinol Wellness has hailed a “transformational” H1 FY26 after slashing its losses […]
Pastilles overtake flower as most prescribed dosage form for women by Steve Jones September 2, 2026September 2, 2026
Members sought for new group to ‘identify and respond’ to regulatory issues by Steve Jones September 1, 2026September 2, 2026
Argent BioPharma halves losses but faces funding ‘uncertainty’ by Adam Sheldon September 1, 2026September 3, 2026
Cann Group entering FY27 with ‘real momentum’, chairman says after year of financial juggling by Steve Jones August 31, 2026August 31, 2026
BLS triples profit, tips revenue to grow up to 55% in FY27 by Adam Sheldon August 31, 2026August 31, 2026
End in sight for Avecho as Phase III CBD trial moves into final stage by Adam Sheldon August 31, 2026August 31, 2026
Losses narrow for ECS Botanics as firm remains bullish despite market challenges by Steve Jones August 31, 2026August 31, 2026
‘Race to the bottom’ not for us, says Vitura as firm moves away from ‘cheap and cheerful’ market by Steve Jones August 28, 2026August 28, 2026
